Why Altimmune Was Such a Robustly Healthy Stock on Thursday

Altimmune (NASDAQ: ALT) had some encouraging news to share with the world as the trading week drew near a close on Thursday. The biotech announced that it will soon ascend to an important, specialized stock index; investors greeted this news by trading the company's stock up by more than 3% on the day. This provided quite a marked contrast to the general trend for stocks, as the S&P 500 index dipped marginally across the session.Before market open, Altimmune divulged that it is being added to the Nasdaq Biotechnology Index (NBI). The move will be effective prior to the trading kickoff next Monday, Dec. 23. Although the index is large and sprawling, with over 600 component stocks, it nevertheless conveys a measure of prestige to those titles. Also, at a stroke, it raises Altimmune's profile and makes the biotech eligible for inclusion in one of the many index funds currently popular among the public. Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool